Imatinib mesylate versus allogeneic BMT for patients with chronic myeloid leukemia in first chronic phase.

2008

Imatinib mesylate versus allogeneic BMT for patients with chronic myeloid leukemia in first chronic phase

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

20

References

24

Citations